Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT05498740
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT05498740
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05498740. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-04 (actual); primary completion 2022-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia
- Acronym
- UltraFuture I
- Condition
- Peripheral Arterial Disease (PAD)
- Intervention (Device)
- Drug eluting Balloon
- Lead sponsor
- Zhejiang Zylox Medical Device Co., Ltd.
Record details
- Record id
cardio:ct-nct05498740- Content hash
e650466ea0a93c159f011ba385b807bb85e36b14c4c0e2c3289252fd22ea1d9d